Research Article
Effects of a Novel Glucokinase Activator, Dorzagliatin, on Glycemic Control and Glucose Fluctuation in Drug-Naïve Patients with Type 2 Diabetes Mellitus
Figure 2
Changes from week 0 to week 52 in HbA1c (a), C120/G120 (b), I120/G120 (c), and HOMA-IR/β/IS (d), with values presented as the mean. , , and vs. the baseline. Error bars show SEM.
(a) |
(b) |
(c) |
(d) |